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background:  Atrial fibrillation (Afib) is the most common arrhythmia in patients (pts) with acute myocardial infarction (MI), nevertheless little is 
known about its influence on the choice of therapeutic strategy and the clinical course of these pts.
methods: The OPTAMI registry (Optimized Therapy of Acute Myocardial Infarction) enrolled consecutive pts with STEMI or NSTEMI in 33 centres (27 
with cathlab) in Germany to document patient characteristics, acute therapy as well as hospital and 1-year outcome. We examined the impact of Afib 
on outcome of MI in the era of reperfusion therapy.
results: A total of 3189 pts were enrolled into OPTAMI. The prevalence of Afib was 5.2% in STEMI and 9.7% in NSTEMI. Pts with Afib were older, 
more often female and had more comorbidities, only 52.3% were taking oral anticoagulants at the time of admission. Primary PCI rates in STEMI 
were similar for pts with and without Afib, wheareas early invasive strategy in NSTEMI was more frequent among pts without Afib. There was no 
difference in the use of DES. Hospital mortality was higher for Afib pts with STEMI but not for those with NSTEMI, probably due to high reperfusion 
rates and overall low mortality. Mortality rates at 1-year were significantly higher among Afib pts for both STEMI and NSTEMI.
Conclusion: Afib was present in 7.4% of MI. Pts with Afib had higher 1-year mortality despite comparable rates of medical and interventional 
treatment. Afib was a significant predictor of impaired outcome of MI even in the era of reperfusion therapy.
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Hospital mortality 12.0% 5.9% <0.05 8.7% 5.1% 0.07
1-year mortality 34.2% 10.8% <0.0001 32.7% 13.9% <0.0001
